Thu Sep 05 07:35:53 UTC 2024: – Solid Biosciences Inc. announced grants of 42,082 restricted stock units to three newly hired employees
– The RSUs vest in four equal installments on each one-year anniversary of the grant date until the fourth anniversary of the grant date
– The grants were made as an inducement material to each employee’s acceptance of employment with the Company
– Solid Biosciences is focused on advancing gene therapy candidates for neuromuscular and cardiac diseases
– The Company’s diverse pipeline includes treatments for Duchenne muscular dystrophy, catecholaminergic polymorphic ventricular tachycardia, and other fatal cardiac diseases
– Solid Biosciences’ goal is to improve the daily lives of patients living with these devastating diseases
– For more information, visit http://www.solidbio.com

Read More